Hosted by HealthpointCapital
Younger, active patients are the fastest-growing group needing shoulder replacement, and today’s implants fail them. Surgeons must choose between an anatomic implant that wears out under an active lifestyle and a reverse implant that sacrifices natural motion. When the first choice no longer works, converting means ripping out well-fixed hardware and starting over, which brings more complications and worse long-term outcomes.
ConvertaTek solves this with the first universal shoulder system that converts between anatomic and reverse, even mid-surgery, on the same non-cemented glenoid and humeral anchors. Patients keep their fixed hardware for life. The patented modular platform covers stemless through stemmed implants, fracture, and revision. It corrects glenoid deformity, eliminates polyethylene wear, and expands range of motion. It runs on just two instrument cases, so it fits the booming outpatient surgery center (ASC) market.
Our founder is an orthopedic surgeon who has had this exact conversion on both of his own shoulders. He’s backed by leading shoulder surgeons and a proven executive team.
We’re raising $5.0M to secure 510(k) clearance and capture an underserved $800M segment, with a plan to reach $51M in revenue by Year 5 after clearance.